To further validate the mechanism by which tetrandrine functions in MGN treatment, we performed KEGG enrichment analysis, the results of which indicated that tetrandrine treatment of MGN was mainly related to the PI3K/Akt signaling pathway. Here, AKT1 is linked to idiopathic membranous glomerulonephritis.